Abstract
Despite costly and time-consuming medical and pharmaceutical research and some promising developments the cancer storm is still blowing and threatening people’s life around the world. There remain numerous challenges with medical diagnosis and treatment approaches, and pharmaceutical faults in finding effective candidates, preparing them as suitable formulations for targeted drug delivery, higher effectiveness and lower adverse reactions, presenting New Drug Applications (NDA) in the cancer field, and developing economical methods for sufficient production of these new drugs. In this chapter, we aim to review the practical solutions like integration of traditional pharmaceutical approaches (pharmacognosy) and modern ones (reverse pharmacognosy), high throughput screening, biotechnology and nanotechnology that may accelerate discovery of new anticancer drugs from natural sources.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aherne W, Garrett M, McDonald T, Workman P (2002) Mechanism-based high throughput screening for novel anticancer drug discovery. In: Baguley BC, Kerr DJ (eds) Anticancer drug development. Academic, New York. doi:10.1016/B978-012072651-6/50015-2
Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno AF, Zhang L, Pridgen E (2008) HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. Chem Med Chem 3:1839–1843. doi:10.1002/cmdc.200800122
Balunas MJ, Kinghorn AD (2005) Drug discovery from medicinal plants. Life Sci 78:431–441. doi:10.1016/j.lfs.2005.09.012
Blondeau S, Do QT, Scior T, Bernard P, Morin-Allory L (2010) Reverse pharmacognosy: another way to harness the generosity of nature. Curr Pharm Des 16(15):1682–1696. doi:10.2174/138161210791164036
Burger, Fiebig (2004) Preclinical screening for new anticancer agents. In: Figg W, McLeoad HL (eds) Handbook of anticancer pharmacokinetics and pharmacodynamics. Springer, New York
Cragg GM, Newman DJ (2004) Plants as a source of anticancer agents. In: Elisabetsky E, Etkin NL (eds) Ethnopharmacology, in encyclopedia of life support system. UNESCO, EOLSS Publishers, UK.
Do QT, Bernard P (2004) Pharmacognosy and reverse pharmacognosy: a new concept for accelerating natural drug discovery. IDrugs 7(11):1017–1027, Pubmed PMID:15551177
Do QT, Renimel I, Andre P, Lugnier C, Muller CD, Bernard P (2005) Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of e-viniferin. Curr Drug Discov Technol 2(3):161–167. doi:10.2174/1570163054866873
Farkya S, Bisaria VS, Srivastava AK (2004) Biotechnological aspects of the production of the anticancer drug podophyllotoxin. Appl Microbiol Biotechnol 65:504–519. doi:10.1007/s00253-004-1680-9
Fuss E (2003) Lignans in plant cell and organ cultures: an overview. Phytochem Rev 2(3):307–320. doi:10.1023/B:PHYT.0000045500.56476.f5
Ionkova I (2011) Anticancer lignans-from discovery to biotechnology. Mini Rev Med Chem 11(10):843–856. doi:10.2174/138955711796575425
Irache JM, Esparza I, Gamazo C, Agueros M, Espuelas S (2011) Nanomedicine: novel approaches in human and veterinary therapeutics. Vet Parasitol 180:47–71. doi:10.1016/j.vetpar.2011.05.028
Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 120:18–26. doi:10.1016/j.jconrel.2007.03.012
Kuhlmann S, Kranz K, Lucking B, Alfermann AW, Petersen M (2002) Aspects of cytotoxic lignan biosynthesis in suspension cultures of Linum nodiflorum. Phytochem Rev 1(1):37–43. doi:10.1023/A:1015876001812
Lee CC, MacKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23:1517–1526. doi:10.1038/nbt1171
Lee AL, Wang Y, Cheng HY, Pervaiz S, Yang YY (2009) The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials 30:919–927. doi:10.1016/j.biomaterials.2008.10.062
Liu Y, Li K, Liu B, Feng SS (2010) A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 31:9145–9155. doi:10.1016/j.biomaterials.2010.08.053
Majumder A, Jha S (2009) Biotechnological approaches for the production of potential anticancer leads podophyllotoxin and paclitaxel: an overview. J Biol Sci 1(1):46–69. http://www.ejarr.com/Volumes/Vol1/EJBS_1_06.pdf. Accessed 8 Aug 2014
Malik S, Biba O, Gruz J, Arroo RRJ, Strnad M (2014) Biotechnological approaches for producing aryltetralin lignans from Linum species. Phytochem Rev. doi:10.1007/s11101-014-9345-5
Misawa M, Goodbody AE (1996) Production of antitumor compounds by plant cell cultures. In: DiCosmo F, Misawa M (eds) Plant cell culture secondary metabolism: toward industrial application. CRC, Boca Raton
Miyano T, Wijagkanalan W, Kawakami S, Yamashita F, Hashida M (2010) Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells. Mol Pharm 7:1318–1327. doi:10.1021/mp100105c
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70(3):461–477. doi:10.1021/np068054v
Patwardhan B, Mashelkar RA (2009) Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today 14:804–811. doi:10.1016/j.drudis.2009.05.009
Petersen M, Alfermann AW (2001) The production of cytotoxic lignans by plant cell cultures. Appl Microbiol Biotechnol 55:135–142. doi:10.1007/s002530000510
Phyton Biotech (2014) Capacity, reliability and quality in taxane API supply. http://www.phytonbiotech.com/images/6169-Phyton_FINAL.jpg. Accessed 8 Aug 2014
Rangel-Yagui CO, Pessoa A, Tavares LC (2005) Micellar solubilization of drugs. J Pharm Pharm Sci 8:147–165, Pubmed PMID:16124926
Ramachandra Rao S, Ravishankar GA (2002) Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv 20(2):101–153. doi:10.1016/S0734-9750(02)00007-1
Roja G, Rao PS (2000) Anticancer compounds from tissue cultures of medicinal plants. J Herbs Apices Med Plants 7(2):71–102. doi:10.1300/J044v07n02_08
Saeidnia S, Abdollahi MA (2014) Perspective studies on novel anticancer drugs from natural origin; a comprehensive review. Int J Pharmacol 10(2):90–108. doi:10.3923/ijp.2014
Silva R, Ferreira H, Cavaco-Paulo A (2011) Sonoproduction of liposomes and protein particles as templates for delivery purposes. Biomacromolecules 12:3353–3368. doi:10.1021/bm200658b
Smetanska I (2008) Production of secondary metabolites using plant cell cultures. Adv Biochem Eng Biotechnol 111:187–228. doi:10.1007/10_2008_103
Sun B, Ranganathan B, Feng SS (2008) Multifunctional poly(D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials 29(4):475–486. doi:10.1016/j.biomaterials.2007.09.038
Tian H, Ip L, Luo H, Chang DC, Luo KQ (2007) A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine. Br J Pharmacol 150(3):321–334. doi:10.1038/sj.bjp.0706988
Wang HC, Yang JH, Hsieh SC, Sheen LY (2010) Allyl sulfides inhibit cell growth of skin cancer cells through induction of DNA damage mediated G2/M arrest and apoptosis. J Agric Food Chem 58:7096–7103. doi:10.1021/jf100613x
Wink M, Alfermann AW, Franke R, Wetterauer B, Distl M, Windhovel J, Krohn O, Fuss E, Garden H, Mohagheghzadeh A, Wildi E, Ripplinger P (2005) Sustainable bioproduction of phytochemicals by plant in vitro cultures: anticancer agents. Plant Genet Resour-C3(2):90–100. doi:10.1079/PGR200575
Yang J, Lee CH, Park J, Seo S, Lim EK, Song YJ, Suh JS, Yoon HG, Huh YM, Haam S (2007) Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer. J Mater Chem 17:2695–2699. doi:10.1039/B702538F
Yousefzadi M, Sharifi M, Behmanesh M, Moyano E, Bonfill M, Cusido RM, Palazon J (2010) Podophyllotoxin: current approaches to its biotechnological production and future challenges. Eng Life Sci 10(4):281–292. doi:10.1002/elsc.201000027
Zhou LG, Wu JY (2006) Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China. Nat Prod Rep 23:789–810. doi:10.1039/b610767b
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 The Author(s)
About this chapter
Cite this chapter
Saeidnia, S. (2015). Anticancer Drug Discovery Approaches; Challenges and Development. In: New Approaches to Natural Anticancer Drugs. SpringerBriefs in Pharmaceutical Science & Drug Development. Springer, Cham. https://doi.org/10.1007/978-3-319-14027-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-14027-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14026-1
Online ISBN: 978-3-319-14027-8
eBook Packages: MedicineMedicine (R0)